DIAGNOS Inc. Share Price

ADK

CA2524423068

IT Services & Consulting

Delayed Toronto S.E. Other stock markets 20:09:47 20/07/2026 BST			5-day change	1st Jan Change
0.2250 ^CAD	0.00%		-15.09%	-40.00%

07-07	Diagnos Announces Warrants Extension	MT
06-18	DIAGNOS to Issue Shares for To Settle $125,000 of Debt	MT

Analysts' recommendations: DIAGNOS Inc.

08/10/25

Diagnos Passes Annual External Quality Audit Program

More recommendations

News in other languages: DIAGNOS Inc.

06-16	DIAGNOS dépose une demande de licence modifiée et mise à jour auprès de Santé Canada pour la plateforme du système CARA
06-05	Emerging Growth Research publie un rapport éclair sur DIAGNOS, mettant en lumière les catalyseurs réglementaires et le potentiel de commercialisation de la plateforme CARA AI
06-03	DIAGNOS présentera à la conférence Emerging Growth le 10 juin 2026
04-08	DIAGNOS fait le point sur les démarches réglementaires et de vente concernant CARA
04-01	DIAGNOS : 2026-04-01, DIAGNOS complète avec succès le processus de renouvellement d’enregistrement d’établissement auprès de la US-FDA – Télécharger le PDF

More news

Managers and Directors: DIAGNOS Inc.

Manager	Title	Age	Since
André Larente CEO	Chief Executive Officer	-	-
Marc-André Massue DFI	Director of Finance/CFO	-	30/04/2008
Yves-Stéphane Couture COO	Chief Operating Officer	-	15/01/2024

Director	Title	Age	Since
André Larente BRD	Director/Board Member	-	20/09/2000
Philippe Couillard CHM	Chairman	69	29/10/2025
Robert Dunn BRD	Director/Board Member	72	27/09/2020

More insiders

Other IT Services & Consulting

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
DIAGNOS INC.	0.00%	-15.09%	+4.65%	-53.61%	19.34M
IBM	+0.28%	-25.74%	-24.30%	+55.75%	200B
SNOWFLAKE INC.	+2.10%	+2.48%	+27.67%	+56.14%	93.2B
ACCENTURE PLC	+0.56%	+4.59%	-48.71%	-53.63%	87.86B
TATA CONSULTANCY SERVICES LTD.	-0.79%	+8.80%	-29.43%	-35.13%	85.25B
RELX PLC	+0.88%	+1.61%	-35.78%	-2.37%	59.17B
INFOSYS LIMITED	-0.86%	+1.79%	-31.46%	-26.30%	46.1B
NEC CORPORATION	-1.96%	+0.48%	+8.01%	+213.82%	35.57B
FUJITSU LIMITED	+1.26%	-1.46%	+1.98%	+79.19%	35.24B
HCL TECHNOLOGIES LIMITED	+1.45%	+4.91%	-21.15%	+4.47%	33.83B
Average	+0.45%	-1.56%	-14.85%	+23.83%	67.61B
Weighted average by Cap.	+0.72%	-4.70%	-19.22%	+26.42%

See all sector performances

Diagnos Inc. is a Canadian company, which is engaged in the early detection of critical eye-related health problems using advanced technology based on Artificial Intelligence (AI). It markets Computer Assisted Retinal Analysis (CARA), a software platform which assists health specialists in the detection of certain retinopathy pathologies through the computerized analysis of retina images. CARA is an in-house-hosted Web-based application that integrates fundus cameras with an image processing engine over a secure Internet connection. The CARA suite of applications allows an eye care specialist to more clearly visualize both normal retinal landmarks (optic nerve, vascular system, macula, fovea), and pathological changes (exudates, haemorrhages, micro-aneurisms, neo-vascularization). CARA is indicated for use by healthcare professionals in an adult general population in the context of a general eye-health exam.

Employees

Sector

IT Services & Consulting

More about the company

Quotes

Date	Price	Change	Volume
20/07/26	CA$0.2250	0.00%	111,940
17/07/26	CA$0.2250	-2.17%	107,021
16/07/26	CA$0.2300	-11.54%	353,433
15/07/26	CA$0.2600	0.00%	252,300
14/07/26	CA$0.2600	-1.89%	224,678

Delayed Quote Toronto S.E.

More quotes

Income Statement and Estimates

More financial data

Annual profits - Rate of surprise

Company calendar

Market Cap	27.09M 19.27M 16.89M 15.61M 14.36M 1.86B 27.53M 187M 73.18M 909M 72.36M 70.78M 3.13B	P/E 2025	-6.18x	P/E 2026	-6.51x
Enterprise Value	26.57M 18.9M 16.56M 15.31M 14.08M 1.82B 26.99M 183M 71.76M 892M 70.96M 69.41M 3.07B	EV / Sales 2025	293x	EV / Sales 2026	498x
Free-Float	95.78%	Yield 2025 *	-	Yield 2026	-

07-07	Diagnos Announces Warrants Extension	MT
06-18	DIAGNOS to Issue Shares for To Settle $125,000 of Debt	MT
06-16	Diagnos Inc Submits Modified And Updated Health Canada Licence Application For Cara System Platform	CI
06-16	Diagnos Submits Modified And Updated Application to Health Canada For CARA Platform	MT
06-11	DIAGNOS Inc. Reports Earnings Results for the Full Year Ended March 31, 2026	CI
06-10	DIAGNOS Inc. Auditor Raises 'Going Concern' Doubt	CI
04-08	Diagnos to submit future CARA version to FDA before end of Q3	RE
04-08	Diagnos Inc Provides Update on Cara Product Regulatory and Commercialization Activities	CI
04-01	Diagnos Renews FDA Medical Device Establishment Registration, Updates On CARA	MT
04-01	Diagnos Inc Successfully Completes Renewal Of US-FDA Medical Device Establishment Registration	CI
02-25	DIAGNOS Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025	CI
02-04	Diagnos, ETS, Announce $1 Million Funding From Federal Govt to Advance AI in Retinal Image Analysis	MT
01-13	Diagnos Inc. Advances Regulatory Strategy for Cara in Key Markets: Updates on Health Canada, Fda, and Sfda Progress	CI

07-07	DIAGNOS to Extend the Exercise Period of Stock Warrants	GL
06-18	DIAGNOS Announces Shares for Debt Settlement	GL
06-16	DIAGNOS Submits Modified and Updated Health Canada Licence Application for CARA System Platform	GL
06-12	DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting	GL
06-05	Emerging Growth Research Releases Flash Report on DIAGNOS, Highlighting Regulatory Catalysts and Commercialization Potential for CARA AI Platform	GL

1 week	-15.09%
Current month	-10.00%
3 months	-10.00%
6 months	-28.57%
Current year	-40.00%

1 week	0.22	0.28
1 month	0.22	0.28
Current year	0.18	0.38
1 year	0.18	0.42
3 years	0.18	0.59
5 years	0.12	0.6
10 years	0.1	2

DIAGNOS Inc. Share Price

Stocks

ADK

CA2524423068

IT Services & Consulting

Valuation: DIAGNOS Inc.

Chart: DIAGNOS Inc.

Latest news : DIAGNOS Inc.

Analysts' recommendations: DIAGNOS Inc.

Press Releases: DIAGNOS Inc.

News in other languages: DIAGNOS Inc.

Quotes and Performance

Course Extremes

Managers and Directors: DIAGNOS Inc.

Latest insider transactions

Other IT Services & Consulting

Financials

Company Profile

Quotes

Income Statement and Estimates

Annual profits - Rate of surprise

Date	Insider	Type	Main position	Quantity	% Market Cap.
11/06/26	Philippe Couillard	Option	Chairman	300,000	0.2491%
11/06/26	Marc-André Massue	Option	Chief Financial Officer	200,000	0.1661%
11/06/26	Michael Braeuel	Option	Director	250,000	0.2076%

	2025	2026
Net sales	104K 73.83K 64.71K 59.81K 55.01K 7.12M 105K 715K 280K 3.48M 277K 271K 12M	65.48K 46.57K 40.82K 37.73K 34.7K 4.49M 66.53K 451K 177K 2.2M 175K 171K 7.57M
Net income	-4.29M -3.05M -2.67M -2.47M -2.27M -294M -4.36M -29.54M -11.58M -144M -11.45M -11.2M -496M	-4.56M -3.24M -2.84M -2.62M -2.41M -312M -4.63M -31.39M -12.3M -153M -12.17M -11.9M -527M
Net Debt	-164K -116K -102K -94.34K -86.76K -11.23M -166K -1.13M -442K -5.49M -437K -428K -18.93M	-525K -374K -327K -303K -278K -36.02M -534K -3.62M -1.42M -17.62M -1.4M -1.37M -60.72M